MacroGenics, Inc. - Common Stock (MGNX)

MGNX earnings call for the period ending December 31, 2024.

MGNX earnings call for the period ending September 30, 2024.

MacroGenics will discontinue vobra duo for remaining mCRPC participants after five deaths. New data to be presented at ESMO 2024 conference.

Match Group layoffs are a hot topic on Wednesday as the dating website operator is preparing to reduce its headcount due to demand changes.

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!

Investors should take a close look at these biotech stocks as they position themselves to provide high returns.

In this recap of the most recent trading session, I discuss earnings results and the market rally seen throughout the past week.

Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets.

MGNX earnings call for the period ending March 31, 2024.